Orange Book product · Generic (ANDA)
MESNA
MESNA
At a glance
Dec 18, 2017
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 18, 2017
8 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
MESNA
Strength
100MG/ML
Dosage form
INJECTABLE
Route
INTRAVENOUS
TE code
AP
Application
ANDA 206992
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MESNA
- 2002MESNEXBrand (NDA)
NDA 020855 · BAXTER HLTHCARE
- 1988MESNEXBrand (NDA)
NDA 019884 · BAXTER HLTHCARE
- 2026MESNAGeneric (ANDA)
ANDA 220518 · EUGIA PHARMA
- 2025MESNAGeneric (ANDA)
ANDA 218871 · INGENUS PHARMS LLC
- 2014MESNAGeneric (ANDA)
ANDA 203364 · RISING
- 2012MESNAGeneric (ANDA)
ANDA 076488 · MYLAN INSTITUTIONAL
- 2010MESNAGeneric (ANDA)
ANDA 090913 · SAGENT PHARMS INC
- 2004MESNAGeneric (ANDA)
ANDA 075739 · HIKMA
- 2001MESNAGeneric (ANDA)
ANDA 075764 · TEVA PHARMS USA
- 2001MESNAGeneric (ANDA)
ANDA 075811 · FRESENIUS KABI USA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
